source
- cAMPfield Therapeutics raises $180 million to develop oral IBD drug prifemilastcAMPfield Therapeutics, a California biotech, announced a $180 million Series A financing to advance its oral anti‑inflammatory candidate for inflammatory bowel disease. The investigational drug,…
- FDA advisory panel unanimously backs Moderna’s flu vaccineThe FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend Moderna’s seasonal influenza vaccine. The vote overturns earlier hesitations from previous agen…